If you are interested in participating in the following trial, please contact the relevant Trial Chairperson or Trial Centre Data Manager.

TROG 99.03/NHLLOW5 - A Randomised Multicentre Trial Of Involved Field Radiotherapy Versus Involved Field Radiotherapy Plus Chemotherapy in combination with Rituximab (MabThera®) For Stage I – II Low Grade Follicular Lymphoma.

Date first patient entered: 14 February 2000

Target Accrual: 200

Aim: To test the hypothesis that six cycles of adjuvant CVP chemotherapy will improve progression-free survival for patients with stage I and II low-grade follicular lymphoma treated with involved-field radiotherapy (IFRT).

Trial Contacts:
Trial Chairpersons
Assoc Prof Michael MacManus
Peter MacCallum Cancer Centre
St Andrews Place, East Melbourne
Fax: +61 3 9656 1424

Dr John Seymour
Peter MacCallum Cancer Centre
St Andrews Place, East Melbourne
Fax: +61 3 9656 1424

Trial Centre Data Manager
Bev McClure
Statistical Centre
Peter MacCallum Cancer Centre
St Andrews Place, East Melbourne VIC 3002
Fax: +61 3 9656 1420

More Information

[ Open Trials - Home ]